Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Armata Pharmaceuticals, Inc.ARMP · Entity 6329 | Director | March 09, 2026 | March 12, 2026 |
| BIOGEN INC.BIIB · Entity 1675 | Chief Financial Officer | February 13, 2026 | February 18, 2026 |
| HERTZ GLOBAL HOLDINGS, INCHTZ · Entity 5147 | Sr VP Chief Accounting Officer | April 29, 2018 | May 01, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Armata Pharmaceuticals, Inc.
Report date March 09, 2026 · Filed March 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.61 · Expires 2036-03-09 | Direct | 25,640 |
Reported balance
After 2026-03-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-09 · Grant · Acquired 25,640 · Balance 25,640 F1: The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date.
BIOGEN INC.
Report date February 13, 2026 · Filed February 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-02-13 | Direct | 8,450 |
Reported balance
After 2026-02-13 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-13 · Grant · Acquired 8,450 · Balance 8,450 F1: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.
HERTZ GLOBAL HOLDINGS, INC
Report date April 29, 2018 · Filed May 01, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,062 |
Ending reported balance
After 2018-04-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-04-29 · Exercise / conversion · Acquired 798 · Balance 6,257 F1: Each Performance Stock Unit represents a contingent right to receive one share of HTZ common stock. The Performance Stock Units were initially granted in 2015 and the amount of Performance Stock Units eligible for vesting is subject to the satisfaction of performance goals for 2016 and 2017. These Performance Stock Units are eligible for vesting based on the satisfaction of the Customer Satisfaction metric, subject to continued employment on the applicable vesting date. Row 2 · 2018-04-29 · Tax withholding · Disposed 195 · Balance 6,062 F2: Shares withheld to pay tax liabilities incident to the vesting of Performance Stock Units. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-04-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-04-29 · Exercise / conversion · Disposed 798 · Balance 0 F1: Each Performance Stock Unit represents a contingent right to receive one share of HTZ common stock. The Performance Stock Units were initially granted in 2015 and the amount of Performance Stock Units eligible for vesting is subject to the satisfaction of performance goals for 2016 and 2017. These Performance Stock Units are eligible for vesting based on the satisfaction of the Customer Satisfaction metric, subject to continued employment on the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Performance Stock Unit represents a contingent right to receive one share of HTZ common stock. The Performance Stock Units were initially granted in 2015 and the amount of Performance Stock Units eligible for vesting is subject to the satisfaction of performance goals for 2016 and 2017. These Performance Stock Units are eligible for vesting based on the satisfaction of the Customer Satisfaction metric, subject to continued employment on the applicable vesting date.
F2: Shares withheld to pay tax liabilities incident to the vesting of Performance Stock Units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2021 Filed Feb 17, 2021 21:59 UTC | BIOGEN INC. BIIB · Entity 1675 | OtherRestricted Stock Unit · Derivative | 166 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006274 · form4.xml · derivative · entry 6 Kramer Robin · CIK 0001609222 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288 Underlying: Common Stock · 166 shares Expires 2022-02-12 F2 · kind: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:59 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionRestricted Stock Unit · Derivative | 120 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006274 · form4.xml · derivative · entry 5 Kramer Robin · CIK 0001609222 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454 Underlying: Common Stock · 120 shares Expires 2022-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:59 UTC | BIOGEN INC. BIIB · Entity 1675 | Tax withholdingCommon Stock | 73 | $278.03 | $20,296.19 |
DisclosureSEC source: 0001127602-21-006274 · form4.xml · nonDerivative · entry 4 Kramer Robin · CIK 0001609222 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 591.446 Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:59 UTC | BIOGEN INC. BIIB · Entity 1675 | Tax withholdingCommon Stock | 42 | $278.03 | $11,677.26 |
DisclosureSEC source: 0001127602-21-006274 · form4.xml · nonDerivative · entry 3 Kramer Robin · CIK 0001609222 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 664.446 Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:59 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionCommon Stock | 213 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006274 · form4.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 706.446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:59 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionCommon Stock | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-006274 · form4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493.446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 21:08 UTC | Armata Pharmaceuticals, Inc. ARMP · Entity 6329 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001104659-20-133639 · tm2038059-7_4seq1.xml · derivative · entry 1 Kramer Robin · CIK 0001609222 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2030-12-08 F1 · derivative.exercise_date: The stock option vests as to fifty percent (50%) of the underlying shares of common stock on each of the first and second annual anniversaries of the date of grant. Read SEC document |
| December 03, 2020 Filed Dec 8, 2020 02:08 UTC | BIOGEN INC. BIIB · Entity 1675 | OtherRestricted Stock Unit · Derivative | 102 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030793 · form4.xml · derivative · entry 4 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178 Underlying: Common Stock · 102 shares Expires 2021-12-03 F2 · shares: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| December 03, 2020 Filed Dec 8, 2020 02:08 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionRestricted Stock Unit · Derivative | 74 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030793 · form4.xml · derivative · entry 3 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280 Underlying: Common Stock · 74 shares Expires 2021-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| December 03, 2020 Filed Dec 8, 2020 02:08 UTC | BIOGEN INC. BIIB · Entity 1675 | Tax withholdingCommon Stock | 22 | $244.09 | $5,369.98 |
DisclosureSEC source: 0001127602-20-030793 · form4.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373.446 Read SEC document |
| December 03, 2020 Filed Dec 8, 2020 02:08 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionCommon Stock | 74 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030793 · form4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395.446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 20:42 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantRestricted Stock Unit · Derivative | 755 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021183 · form4.xml · derivative · entry 2 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 755 Underlying: Common Stock · 755 shares Expires 2023-07-01 F2 · derivative.exercise_date: The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 07/01/2020. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:37 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantRestricted Stock Unit · Derivative | 1,510 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005782 · form4.xml · derivative · entry 5 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,510 Underlying: Common Stock · 1,510 shares Expires 2023-02-12 F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:37 UTC | BIOGEN INC. BIIB · Entity 1675 | OtherRestricted Stock Unit · Derivative | 154 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005782 · form4.xml · derivative · entry 4 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 574 Underlying: Common Stock · 154 shares Expires 2022-02-12 F2 · shares: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:37 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionRestricted Stock Unit · Derivative | 132 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005782 · form4.xml · derivative · entry 3 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 728 Underlying: Common Stock · 132 shares Expires 2022-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:37 UTC | BIOGEN INC. BIIB · Entity 1675 | Tax withholdingCommon Stock | 46 | $331.76 | $15,260.96 |
DisclosureSEC source: 0001127602-20-005782 · form4.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236.481 Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 23:37 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionCommon Stock | 132 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-005782 · form4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282.481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:24 UTC | BIOGEN INC. BIIB · Entity 1675 | OtherRestricted Stock Unit · Derivative | 92 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034363 · form4.xml · derivative · entry 4 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354 Underlying: Common Stock · 92 shares Expires 2021-12-03 F4 · shares: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number that vested. F3 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:24 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionRestricted Stock Unit · Derivative | 84 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034363 · form4.xml · derivative · entry 3 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 446 Underlying: Common Stock · 84 shares Expires 2021-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:24 UTC | BIOGEN INC. BIIB · Entity 1675 | Tax withholdingCommon Stock | 25 | $290.70 | $7,267.50 |
DisclosureSEC source: 0001127602-19-034363 · form4.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150.481 Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:24 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionCommon Stock | 84 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-034363 · form4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175.481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 51.685 shares acquired under the Biogen Inc. employee stock purchase plan on 3/29/2019. F2 · balance_after: Includes 39.796 shares acquired under the Biogen Inc. employee stock purchase plan on 6/28/2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 23:15 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantRestricted Stock Unit · Derivative | 860 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006086 · form4.xml · derivative · entry 1 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 860 Underlying: Common Stock · 860 shares Expires 2022-02-12 F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:20 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantRestricted Stock Unit · Derivative | 265 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-035371 · form4.xml · derivative · entry 2 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 Underlying: Common Stock · 265 shares Expires 2021-12-03 Read SEC document |
| December 03, 2018 Filed Dec 6, 2018 21:20 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantRestricted Stock Unit · Derivative | 530 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-035371 · form4.xml · derivative · entry 1 Kramer Robin · CIK 0001609222 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530 Underlying: Common Stock · 530 shares Expires 2021-12-03 F1 · derivative.exercise_date: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]). Read SEC document |
| April 29, 2018 Filed May 1, 2018 19:15 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Exercise / conversionPerformance Stock Units · Derivative | 798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-18-005592 · wf-form4_152521649341427.xml · derivative · entry 3 Kramer Robin · CIK 0001609222 · Sr VP Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 798 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Performance Stock Unit represents a contingent right to receive one share of HTZ common stock. The Performance Stock Units were initially granted in 2015 and the amount of Performance Stock Units eligible for vesting is subject to the satisfaction of performance goals for 2016 and 2017. These Performance Stock Units are eligible for vesting based on the satisfaction of the Customer Satisfaction metric, subject to continued employment on the applicable vesting date. F1 · price: Each Performance Stock Unit represents a contingent right to receive one share of HTZ common stock. The Performance Stock Units were initially granted in 2015 and the amount of Performance Stock Units eligible for vesting is subject to the satisfaction of performance goals for 2016 and 2017. These Performance Stock Units are eligible for vesting based on the satisfaction of the Customer Satisfaction metric, subject to continued employment on the applicable vesting date. F1 · derivative.exercise_date: Each Performance Stock Unit represents a contingent right to receive one share of HTZ common stock. The Performance Stock Units were initially granted in 2015 and the amount of Performance Stock Units eligible for vesting is subject to the satisfaction of performance goals for 2016 and 2017. These Performance Stock Units are eligible for vesting based on the satisfaction of the Customer Satisfaction metric, subject to continued employment on the applicable vesting date. F1 · derivative.expiration_date: Each Performance Stock Unit represents a contingent right to receive one share of HTZ common stock. The Performance Stock Units were initially granted in 2015 and the amount of Performance Stock Units eligible for vesting is subject to the satisfaction of performance goals for 2016 and 2017. These Performance Stock Units are eligible for vesting based on the satisfaction of the Customer Satisfaction metric, subject to continued employment on the applicable vesting date. Read SEC document |
| April 29, 2018 Filed May 1, 2018 19:15 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Tax withholdingCommon Stock | 195 | $21.94 | $4,278.30 |
DisclosureSEC source: 0001628280-18-005592 · wf-form4_152521649341427.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · Sr VP Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,062 F2 · shares: Shares withheld to pay tax liabilities incident to the vesting of Performance Stock Units. Read SEC document |
| April 29, 2018 Filed May 1, 2018 19:15 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Exercise / conversionCommon Stock | 798 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-18-005592 · wf-form4_152521649341427.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · Sr VP Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Performance Stock Unit represents a contingent right to receive one share of HTZ common stock. The Performance Stock Units were initially granted in 2015 and the amount of Performance Stock Units eligible for vesting is subject to the satisfaction of performance goals for 2016 and 2017. These Performance Stock Units are eligible for vesting based on the satisfaction of the Customer Satisfaction metric, subject to continued employment on the applicable vesting date. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:20 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | SaleCommon Stock | 5,450 | $19.67 | $107,201.50 |
DisclosureSEC source: 0001104659-18-016849 · a4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · Sr VP Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,459 F1 · price: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $19.650 to $19.720. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or any staff member of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2018 Filed Mar 6, 2018 21:59 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | GrantEmployee Stock Option · Derivative | 7,846 | $0.00 Strike: $17.73 | $0.00 |
DisclosureSEC source: 0001104659-18-015343 · a4.xml · derivative · entry 6 Kramer Robin · CIK 0001609222 · Sr. VP, Chief Acc Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,846 Underlying: Common Stock · 7,846 shares Expires 2025-03-02 F2 · derivative.exercise_date: These stock options were granted on March 2, 2018 and will vest 25% on each anniversary of the date of grant, subject to the reporting person's continued employment. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:59 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | OtherPerformance Stock Unit · Derivative | 13,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-015343 · a4.xml · derivative · entry 7 Kramer Robin · CIK 0001609222 · Sr. VP, Chief Acc Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,302 shares Expires not disclosed F3 · derivative.exercise_price: These performance stock units were granted and vested on March 2, 2018 in connection with the Company's payments under its 2017 annual bonus plan. The performance stock units were granted in lieu of providing a cash bonus to the reporting person earned for 2017 performance. F3 · derivative.exercise_date: These performance stock units were granted and vested on March 2, 2018 in connection with the Company's payments under its 2017 annual bonus plan. The performance stock units were granted in lieu of providing a cash bonus to the reporting person earned for 2017 performance. F3 · derivative.expiration_date: These performance stock units were granted and vested on March 2, 2018 in connection with the Company's payments under its 2017 annual bonus plan. The performance stock units were granted in lieu of providing a cash bonus to the reporting person earned for 2017 performance. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:59 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Exercise / conversionRestricted Stock · Derivative | 1,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-015343 · a4.xml · derivative · entry 5 Kramer Robin · CIK 0001609222 · Sr. VP, Chief Acc Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,404 Underlying: Common Stock · 1,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of restricted stock were granted in 2017 and we earned based on achieving revenue goals for 2017. The first tranche vested on March 2, 2018 after the certification of performance for the restricted stock. The remaining tranches will vest on the second and third anniversaries of the date of grant, subject to continued employment. F1 · derivative.exercise_date: These shares of restricted stock were granted in 2017 and we earned based on achieving revenue goals for 2017. The first tranche vested on March 2, 2018 after the certification of performance for the restricted stock. The remaining tranches will vest on the second and third anniversaries of the date of grant, subject to continued employment. F1 · derivative.expiration_date: These shares of restricted stock were granted in 2017 and we earned based on achieving revenue goals for 2017. The first tranche vested on March 2, 2018 after the certification of performance for the restricted stock. The remaining tranches will vest on the second and third anniversaries of the date of grant, subject to continued employment. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:59 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Tax withholdingCommon Stock | 3,237 | $18.69 | $60,499.53 |
DisclosureSEC source: 0001104659-18-015343 · a4.xml · nonDerivative · entry 4 Kramer Robin · CIK 0001609222 · Sr. VP, Chief Acc Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,909 Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:59 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Exercise / conversionCommon Stock | 13,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-015343 · a4.xml · nonDerivative · entry 3 Kramer Robin · CIK 0001609222 · Sr. VP, Chief Acc Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:59 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Tax withholdingCommon Stock | 357 | $18.69 | $6,672.33 |
DisclosureSEC source: 0001104659-18-015343 · a4.xml · nonDerivative · entry 2 Kramer Robin · CIK 0001609222 · Sr. VP, Chief Acc Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 844 Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:59 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Exercise / conversionCommon Stock | 1,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-015343 · a4.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · Sr. VP, Chief Acc Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2017 Filed Sep 15, 2017 16:05 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | SaleCommon Stock | 3,524 | $21.53 | $75,882.64 |
DisclosureSEC source: 0001140361-17-035666 · doc1.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · Sr VP, ChiefAccountingOfficer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,065 F1 · balance_after: Includes 4,065 restricted stock units, each representing a contingent right to receive one share of HTZ Common Stock, 100% of which will vest on March 3, 2019. Read SEC document |
| May 15, 2017 Filed May 16, 2017 10:04 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | Tax withholdingCommon Stock | 497 | $10.69 | $5,312.93 |
DisclosureSEC source: 0001140361-17-020898 · doc1.xml · nonDerivative · entry 1 Kramer Robin · CIK 0001609222 · Sr VP, ChiefAccountingOfficer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,607 F1 · shares: Shares withheld to pay tax liabilities incident to the vesting of Restricted Stock Units. F2 · balance_after: Includes 4,065 restricted stock units, each representing a contingent right to receive one share of HTZ Common Stock, 100% of which will vest on March 3, 2019. Read SEC document |
| March 02, 2017 Filed Apr 6, 2017 13:44 UTC | HERTZ GLOBAL HOLDINGS, INC HTZ · Entity 5147 | GrantEmployee Stock Option (Right to Purchase) · Derivative | 8,554 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001140361-17-015110 · doc1.xml · derivative · entry 1 Kramer Robin · CIK 0001609222 · Sr VP, ChiefAccountingOfficer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,554 Underlying: Common Stock · 8,554 shares Expires 2024-03-02 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 2, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.